2019台灣生技月 Bio Taiwan 生物科技大展

2019 台灣生技月 南港展覽館

同期會議

澳洲臨床試驗研討會

​澳洲辦事處為推動台灣、澳洲生技醫藥產業合作與國際市場發展,將於7月24日舉辦「澳洲臨床試驗研討會暨商談會」。邀請四家澳洲臨床試驗服務廠商針對澳洲生技醫藥研發環境、臨床研究基礎、高效的監管體系以及R&D稅額獎勵制度進行主題演講。同時也邀請已成功赴澳進行早期臨床試驗的台灣生技新藥公司進行經驗分享。誠摯邀請您的參與,也歡迎您與澳洲廠商進行一對一商談!
 
日期|20190724 () 09:30 報到
地點|澳洲辦事處 (台北市信義區松高路1127 統一國際大樓)
費用|免費,並敬備午餐

報名連結 & 商談預約|https://forms.gle/zF7w7XWvoikFHBHA8
邀請函|https://drive.google.com/file/d/1AiQFYd5X1PFr7kUnNzjJJj5hIan2iSUE/view?usp=sharing

議程:

09:30 – 10:00    與會者報到
10:00 – 10:10    開幕致詞
   澳洲辦事處副代表 Eliza Chui
「澳洲臨床試驗」產業發展與優勢
10:10 – 12:00      Accelerating clinical trials in             Australia and Asia       John Moller, CEO
      Novotech (Australia) Pty Ltd
    Conducting First in Human                (Early Phase) Clinical Trials in              Australia      Cameron Johnson, CEO
     Nucleus Network
    Australian capabilities in                     neuroscience trials      Kathy Skoff, Business Integration           Manager
     Neuroscience Trials Australia
     Australian Clinical Trials:                  Corporate Structuring & R&D                Incentives      Blair Lucas, CEO & Partner
     CoSec Consulting Pty Ltd
   前進澳洲:臨床試驗經驗分享      葉志鴻 總經理
     台灣微脂體 (TLC)
12:00 – 13:30    午餐交流
13:30 – 16:30    一對一商談


澳洲廠商簡介|
 
Novotech https://novotech-cro.com/
Headquartered in Sydney, Novotech is internationally recognized as the leading regional full-service contract research organization (CRO). Novotech has been instrumental in the success of hundreds of Phase I – IV clinical trials in the Asia Pacific region. Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management.
 
Nucleus Network https://nucleusnetwork.com.au/
Nucleus is Australia’s only multi-site dedicated phase I clinical research organization with phase I facilities located in Melbourne (80 beds) and Brisbane (60 beds). The phase I units are strategically co-located within The Alfred Hospital in Melbourne and within Royal Brisbane and Women’s Hospital in Brisbane. This combination provides Nucleus with access to a total population of 7.5million people and the ability to offer a multi-site solution in recruiting participants and patients to our clients.
 
Neuroscience Trials Australia http://www.neurotrialsaustralia.com/
Neuroscience Trials Australia is a unique, CNS-focused CRO specializing in all phases and aspects of neuroscience clinical research. Our strategic alliances with many therapeutic disease groups provides access to key opinion leaders, experienced sites and clinical trial expertise through a range of tailored services. Our extensive network of world-leading clinical experts means projects are successfully delivered in a cost-effective and timely manner with tax benefits to halve the cost of your trial.
 
CoSec Consulting http://cosec.com.au/
CoSec provides the corporate structure and compliance services required to run clinical trials in Australia and quality for Australia’s R&D tax Incentive. Our suite of integrated compliance, management, and advisory services allows you to fulfil all your regulatory and reporting obligations in Australia. We work closely with a network of trusted service providers - including CROs and legal advisors - to ensure that your objectives for clinical trials are met in Australia.
 
聯絡資訊|
張篤理 (Duli Chang)
資深商務經理 – 生技醫藥產業組
Tel: +886 2 8758 4207
Email: duli.chang@austrade.gov.au
 
黃皓偉 (Hao-wei Huang)
商務經理 – 生技醫藥產業組
Tel: +886 2 8758 4203
Email: haowei.huang@austrade.gov.au